scholarly article | Q13442814 |
P50 | author | Thomas Burris | Q67982842 |
P2093 | author name string | Cyrielle Billon | |
Sadichha Sitaula | |||
P2860 | cites work | Interleukin-4 deficiency promotes gallstone formation | Q24295010 |
Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol | Q24306058 | ||
Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis | Q24642725 | ||
T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma | Q28506783 | ||
Atherosclerosis. the road ahead | Q29618972 | ||
Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation | Q34474230 | ||
Homozygous staggerer (sg/sg) mice display improved insulin sensitivity and enhanced glucose uptake in skeletal muscle | Q34768447 | ||
Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism | Q34976906 | ||
Transcriptional profiling reveals a role for RORalpha in regulating gene expression in obesity-associated inflammation and hepatic steatosis | Q35095209 | ||
Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand | Q35143424 | ||
Attenuated atherosclerotic lesions in apoE-Fcγ-chain-deficient hyperlipidemic mouse model is associated with inhibition of Th17 cells and promotion of regulatory T cells | Q35566640 | ||
Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice | Q36202916 | ||
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis | Q37377439 | ||
The T(reg)/Th17 cell balance: a new paradigm for autoimmunity | Q37393703 | ||
T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia | Q43624009 | ||
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease | Q56902429 | ||
Natural regulatory T cells control the development of atherosclerosis in mice | Q58149268 | ||
Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha | Q77677370 | ||
Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis | Q79711302 | ||
Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall | Q85054596 | ||
CD4+ T cells in atherosclerosis: regulation by platelets | Q86213488 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 10 | |
P921 | main subject | inflammation | Q101991 |
atherosclerosis | Q12252367 | ||
P304 | page(s) | 997-1005 | |
P577 | publication date | 2016-07-25 | |
P1433 | published in | Molecular Metabolism | Q27724805 |
P1476 | title | Inhibition of RORα/γ suppresses atherosclerosis via inhibition of both cholesterol absorption and inflammation | |
P478 | volume | 5 |
Q92540743 | A Critical Role of PCSK9 in Mediating IL-17-Producing T Cell Responses in Hyperlipidemia |
Q50055223 | Adropin: An endocrine link between the biological clock and cholesterol homeostasis |
Q51132724 | Central role of T helper 17 cells in chronic hypoxia-induced pulmonary hypertension. |
Q88921523 | Emerging role of circadian clock disruption in alcohol-induced liver disease |
Q38661300 | Metabolic Characterization of a Novel RORα Knockout Mouse Model without Ataxia |
Q89296979 | Pharmacological activation of REV-ERBα represses LPS-induced microglial activation through the NF-κB pathway |
Q93222327 | RORγ regulates the NLRP3 inflammasome |
Q88141299 | Retinoic acid-related Orphan Receptor γ (RORγ): connecting sterol metabolism to regulation of the immune system and autoimmune disease |
Q61812343 | Small Molecule Modulators of the Circadian Molecular Clock With Implications for Neuropsychiatric Diseases |